Home
Profile Team Clients and Collaborators
Genomics Structural Biology Writing Assistance AI/ML in Life Science
R &D
Careers
Blogs
Publications
Contact us

Drug Discovery Platform with Hardware

Analogue Platform

Publications

Identifying potential compounds from Bacopa monnieri (brahmi) against coxsackievirus A16 RdRp targeting HFM disease (tomato flu) (2023)

Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2 (2022)

Synergistic Effects of Natural Compounds Toward Inhibition of SARS-CoV-2 3CL Protease (2021)

Efficient toxicity prediction via simple features using shallow neural networks and decision trees (2019)

RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2 (2022)

Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 (2022)

Structure-based design of small peptide ligands to inhibit early-stage protein aggregation nucleation (2020)

Differentiating stable and unstable protein using convolution neural network and molecular dynamics simulations (2024)

Machine bLearning Optimization Approach to Design Multi-Epitope Marburg Vaccine Construct (2024)

Mechanistic Explanation of Activation and Inhibition of Crucial Enzymes Involved in Melanin Production (2024)

Higher concentration of trehalose dihydrate stabilizes recombinant IgG1 under forced stress conditions (2025)

Growdea Technologies Pvt Ltd, an in-silico life science company focussing on application of AI/ML & high end computational techniques to address current problems in biology, incorporated in 2018.

  • bd@growdeatech.com
  • +91-124-4466292
Facebook Instagram Linkedin Telegram Twitter Youtube